Skip to main content Skip to main navigation menu Skip to site footer
logo Dermatology Reports

eISSN 2036-7406

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Early Access
  • Register
  • Login
  • Search
  • Contacts

Editor-in-Chief: Carlo Cota, Italy

1.0
Impact Factor 2025
1.5
CiteScore 2025
1.0
Impact Factor 2025
1.5
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

    Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi
    13-09-2023
    https://doi.org/10.4081/dr.2023.9839
    2840
    PDF: 1008
    HTML: 38
  • Combined cetuximab and volumetric modulated arc-radiotherapy in advanced recurrent squamous cell carcinoma of the scalp

    Uwe Wollina, Andreas Schreiber, Knut Merla, Gunter Haroske
    e57
    13-12-2011
    https://doi.org/10.4081/dr.2011.e57
    1940
    PDF: 744
    HTML: 1027
  • Efficacy of autologous serum therapy in positive and negative autologous serum skin test patients in chronic urticaria in a tertiary care centre

    Raghavendra KR, Bangaru H
    06-07-2022
    https://doi.org/10.4081/dr.2022.9525
    2171
    PDF: 589
    HTML: 72
  • Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

    Paolo Dapavo, Matteo Megna, Marina Talamonti
    09-08-2024
    https://doi.org/10.4081/dr.2024.9999
    1825
    PDF: 725
    HTML: 102
  • New and emerging therapies in cutaneous T-cell lymphoma

    Gabriele Roccuzzo, Nicole Macagno, Silvia Giordano, Paolo Fava, Pietro Quaglino
    02-10-2024
    https://doi.org/10.4081/dr.2024.10002
    1185
    PDF: 667
    HTML: 107
  • Atopic dermatitis: a brief review of recent advances in its management

    Sultan Daghafak Alenazi
    23-05-2023
    https://doi.org/10.4081/dr.2023.9678
    2497
    PDF: 1445
    HTML: 122
  • Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

    Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło
    22-05-2023
    https://doi.org/10.4081/dr.2023.9630
    1109
    PDF: 588
    HTML: 90
  • A rare case of keloid combined with bullous pemphigoid

    Ying Zhang, Yiyi Gong, Xiangguang Shi, Huyan Chen, Yining Wei, Wenyu Wu, Mengguo Liu
    09-10-2025
    https://doi.org/10.4081/dr.2025.10484
    1061
    PDF: 240
    HTML: 0
  • Mortality risk factors in febrile ulceronecrotic Mucha- Habermann disease: a systematic review of therapeutic outcomes and complications

    Vasiliki Tasouli-Drakou, May Nguyen, Hannah Guinn, Omron Hassan, Sneha Butala, Sheshanna Phan
    21-11-2022
    https://doi.org/10.4081/dr.2022.9492
    1809
    PDF: 697
    HTML: 91
  • Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

    Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen
    11-10-2017
    https://doi.org/10.4081/dr.2017.7079
    1427
    PDF: 683
    HTML: 146
  • Erythrodermic psoriasis improved by tildrakizumab

    Giampaolo Trevisan, Lerica Germi, Luigi Naldi
    23-11-2022
    https://doi.org/10.4081/dr.2022.9448
    1329
    PDF: 638
    HTML: 26
  • The efficacy of apremilast in pemphigus: a systematic review of case reports

    Roudin H. Alhasawi, Esraa A. Shaheen, Noura M. Alshabanat, Reem Brashi, Walaa Abdu Ahmed, Shumukh H. Alqahtani, Ethar G. Alharbi, Mazin Aljabri
    07-05-2025
    https://doi.org/10.4081/dr.2025.10245
    1013
    PDF: 448
    SUPPLEMENTARY MATERIAL: 64
    HTML: 18
  • Paradoxical reaction under dupilumab triggered by occasional ketoprofen intake

    Filippo Chersi, Sanja Javor, Rosella Gallo, Elia Sala, Cesare Massone
    28-02-2025
    https://doi.org/10.4081/dr.2025.10214
    978
    PDF: 752
    HTML: 13
  • Epidermolysis bullosa acquisita: current diagnosis and therapy

    Christine R. Mehren, Robert Gniadecki
    e38
    28-11-2011
    https://doi.org/10.4081/dr.2011.e38
    1637
    PDF: 911
    HTML: 131
  • Primary cutaneous marginal zone lymphoma in a patient with multiple sclerosis under fingolimod therapy

    Thilo Gambichler, Sera Selina Weyer-Fahlbusch, Markus Werner, Ulrika Schade, Lieselotte Bissels, Laura Susok
    11-07-2025
    https://doi.org/10.4081/dr.2025.10237
    488
    PDF: 314
    HTML: 10
  • Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

    Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero
    17-03-2022
    https://doi.org/10.4081/dr.2022.9282
    1200
    PDF: 856
    HTML: 47
  • Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

    Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza
    21-11-2022
    https://doi.org/10.4081/dr.2022.9447
    1418
    PDF: 426
    HTML: 49
  • Rituximab for linear immunoglobulin A bullous dermatosis

    Rummit Dhillon, Lily Park, Sarah Gabros, Tam Nguyen, Stanley Skopit
    29-12-2022
    https://doi.org/10.4081/dr.2023.9574
    1598
    PDF: 586
    HTML: 42
  • CD4/CD8 double-negative mycosis fungoides: a review

    Khalid Nabil Nagshabandi, Abdulrahman Shadid, Asem Shadid, Nouf K. Almuhanna
    12-04-2024
    https://doi.org/10.4081/dr.2024.9908
    3306
    PDF: 655
    SUPPLEMENTARY: 128
    HTML: 34
  • Metastatic basal cell carcinoma to the bone: a case of bone metastasis in uncommon sites

    Olga Nigro, Claudio Chini, Ilaria Gioia Angiola Marcon, Annamaria De Giorgi, Linda Bascialla, Elisa Gallerani, Alice Giaquinto, Diego De Palma, Maurizio Lombardo
    12-07-2022
    https://doi.org/10.4081/dr.2022.9267
    1113
    PDF: 524
    Supplementary Table: 245
    HTML: 19
  • COVID-19 infection in chronic spontaneous urticaria treated with omalizumab: two case reports

    Angelo Massimiliano D'Erme, Cristian Fidanzi, Marco Romanelli, Valentina Dini, Giovanni Bagnoni, Agata Janowska
    24-08-2023
    https://doi.org/10.4081/dr.2023.9763
    817
    PDF: 435
    HTML: 35
  • Ultrasound monitoring of hidradenitis suppurativa fistulas in treatment with adalimumab

    Raffaele Dante Caposiena Caro, Giulia Bazzacco, Enrico Zelin, Vanessa Mazzoletti, Nicola Di Meo, Iris Zalaudek
    11-04-2025
    https://doi.org/10.4081/dr.2025.10124
    660
    PDF: 441
    HTML: 10
  • Vulvar malignant melanoma: a case report and review of its management

    Maizatulernawani Hashim, Nor Hidayah Yayanto, Badrul Zaman Muda Abdullah, Fathi Ramly, Rahimah Abd Rashid, Daniel Roza Duski
    04-07-2022
    https://doi.org/10.4081/dr.2022.9345
    1656
    PDF: 449
    HTML: 275
  • Bullous mycosis fungoides associated with an extensive ulcer and a severe leukemoid reaction

    Shuei Sato, Osamu Okamoto, Michifumi Kawamoto, Masaki Oishi, Naomi Yada, Kazuhiro Kohno, Shigeo Yokoyama, Sakuhei Fujiwara
    e54
    02-12-2011
    https://doi.org/10.4081/dr.2011.e54
    1335
    PDF: 700
    HTML: 125
  • Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy

    Marco May Lee, Vito Di Lernia, Francesca Peccerillo, Federico Bardazzi, Michela Tabanelli, Michela Ricci, Davide Melandri, Monica Corazza, Francesca Satolli, Andrea Conti
    01-07-2025
    https://doi.org/10.4081/dr.2025.10315
    612
    PDF: 313
    HTML: 22
1 - 25 of 42 items 1 2 > >> 

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a Scientific paper
  • How to write a Review article
  • Article Processing Charge
  • Crediti ECM (Italian Authors)

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to Review
  • Thanks to Reviewers

Categories

    • XXXI Congresso Nazionale Intergruppo Melanoma Italiano (IMI)
    • IMI - Epidemiology, genetics and pathogenesis
    • IMI - Prevention and diagnosis
    • IMI - Pathological and molecular classification
    • IMI - Surgery
    • IMI - Therapy
    • Newsletter
    • Original Articles
    • Reviews
    • Case Reports

indexing

INDEXING
  • PubMed
  • PubMed Central
  • Scopus
  • DOAJ
  • ESCI
  • Google Scholar
  • OpenAlex
  • Web of Science
  • Analytics

dermatopathology

Dermatopathology

Dermatology Reports

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

 

https://godisnjak.pf.unibl.org/

https://revistascientificas.us.es/

pISSN: 2036-7392
eISSN: 2036-7406

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.